City

Bethesda (1)

Chicago (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

IGF Oncology, LLC (1)

National Cancer Institute (NCI) (1)

Collaborator

Intervention

igf-methotrexate conjugate (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

NIH (1)

Study Type

Interventional (1)

Observational (1)

thoracic cancers

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Blood and Tissue in Cancers of Lung, Esophagus and Lung Lining

Recruiting

Malignant Pleural Mesotheliomas NOS
+4 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 18, 2023

Breast Cancer, Brain Cancer, Gastrointestinal Cancers Trial in Chicago (IGF-Methotrexate conjugate)

Completed

Breast Cancer
+7 more

IGF-Methotrexate conjugate

Chicago, Illinois

University of Illinois at Chicago

Aug 20, 2019